2 months ago
MGNX
AnalystsPeter LawsonPeter Lawson's Stock Forecasts
AnalystsPeter Lawson
Analyst Ranking
Top 23%
#1033 out of 4563 analysts
Average Return
+4.49%
Win Rate
42%28 out of 67
Risk vs Reward
Poor
Good
Peter Lawson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunogen IncIMGN | +214.57% | $5.01 | $15.76 | 2022-11-15 - 2023-11-14 | Strong Buy |
Immunogen IncIMGN | +187.55% | $5.46 | $15.70 | 2022-09-09 - 2023-09-08 | Strong Buy |
Immunomedics IncIMMU | +171.17% | $32.40 | $87.86 | 2020-05-05 - 2020-10-22 | Strong Buy |
Fate Therapeutics IncFATE | +170.37% | $30.75 | $83.14 | 2020-03-04 - 2021-03-04 | Strong Buy |
Arvinas IncARVN | +120.46% | $14.76 | $32.54 | 2023-10-24 - 2024-04-24 | Strong Buy |
Peter Lawson Analyst Color
Get additional color on Peter Lawson's coverage of popular stocks
2 months ago
ARVN
2 months ago
MGNX
2 months ago
SWTX
3 months ago
EXEL
3 months ago
SWTX
9 months ago
SNDX
10 months ago
IMGN
Peter Lawson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 4 | Hold | $25.00 | +5.44% | Downgrades | 14 days ago |
Macrogenics IncMGNX | 5 | Strong Buy | $25.00 | +59.24% | Maintains | 2 months ago |
Tscan Therapeutics IncTCRX | 1 | Strong Buy | $9.00 | +21.95% | Maintains | 2 months ago |
Arvinas IncARVN | 5 | Strong Buy | $60.00 | +84.39% | Maintains | 2 months ago |
Iovance Biotherapeutics IncIOVA | 4 | Strong Buy | $22.00 | +87.87% | Maintains | 2 months ago |
Springworks Therapeutics IncSWTX | 3 | Strong Buy | $63.00 | +45.23% | Maintains | 2 months ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | +132.56% | Maintains | 2 months ago |
Blueprint Medicines CorpBPMC | 7 | Hold | $70.00 | -24.13% | Maintains | 2 months ago |
Replimune Group IncREPL | 2 | Strong Buy | $13.00 | +105.37% | Maintains | 5 months ago |
Immunogen IncIMGN | 5 | Hold | $31.00 | -0.74% | Downgrades | 5 months ago |
Exscientia PLCEXAI | 2 | Strong Buy | $10.00 | +142.13% | Maintains | 6 months ago |
Adaptimmune Therapeutics PLCADAP | 2 | Strong Sell | $1.00 | -7.41% | Maintains | 8 months ago |
Prelude Therapeutics IncPRLD | 4 | Hold | $5.00 | +29.20% | Maintains | 9 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $34.00 | +63.54% | Maintains | 9 months ago |
Biomea Fusion IncBMEA | 1 | Strong Buy | $50.00 | +364.25% | Initiates Coverage On | a year ago |
Relay Therapeutics IncRLAY | 2 | Hold | $15.00 | N/A | Maintains | a year ago |
Nurix Therapeutics IncNRIX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Deciphera Pharmaceuticals IncDCPH | 5 | Strong Sell | $9.00 | N/A | Maintains | a year ago |
Arcus Biosciences IncRCUS | 4 | Strong Buy | $35.00 | N/A | Maintains | a year ago |
Immunocore Holdings PLCIMCR | 1 | Strong Buy | $80.00 | N/A | Initiates Coverage On | a year ago |
Neximmune IncNEXI | 2 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Karyopharm Therapeutics IncKPTI | 2 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Cytomx Therapeutics IncCTMX | 3 | Strong Buy | $3.50 | N/A | Maintains | 2 years ago |
Illumina IncILMN | 1 | Strong Sell | $365.00 | N/A | Maintains | 3 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Strong Buy | $46.00 | N/A | Upgrades | 4 years ago |
Immunomedics IncIMMU | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Epizyme IncEPZM | 1 | Strong Buy | $33.00 | N/A | Initiates Coverage On | 4 years ago |
Xencor IncXNCR | 1 | Strong Sell | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Nektar TherapeuticsNKTR | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 5 years ago |
Celyad Oncology SaCYADY | 1 | Strong Buy | $49.00 | N/A | Initiates Coverage On | 6 years ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $45.00 | N/A | Upgrades | 6 years ago |
Crispr Therapeutics AgCRSP | 1 | Strong Buy | $45.00 | N/A | Upgrades | 6 years ago |
Juno Therapeutics IncJUNO | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Affimed NvAFMD | 1 | Strong Buy | $70.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.